Isomab Ltd
13972139
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/03/2025
micro entity
Next accounts due
31/12/2026
Confirmation statement
Last: 10/03/2026
Due 24/03/2027
Industry
Officers
director · Since 11/03/2022
DIRECTOR
BRITISH · ENGLAND · Age 58
Also on 2 other boards
director · Since 01/07/2022
DIRECTOR
BRITISH · ENGLAND · Age 69
Also on 3 other boards
director · Since 12/02/2024
VENTURE CAPITAL INVESTOR
AMERICAN · UNITED STATES · Age 62
director · Since 05/09/2024
VENTURE CAPITAL
BRITISH · ENGLAND · Age 37
Also on 1 other board
secretary · Since 24/07/2025
Persons with Significant Control
Former PSCs
Professor David Owen Bates
Ceased 12/02/2024
CompanyRankvs 1110+ SIC 72110 peers77
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£3.8M
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£3.9M
Working capital
Current Assets
£4.2M
Current Liabilities
£476k
Fixed Assets
£16k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 8.73 | +£3.4M |
| 2023 | 2.73 | — |
Derived from filed accounts. Not audited figures.